The International Pharma Federation (IPF) arranged a pharmaceutical conference on 23 January 2026 at Hotel KC Cross Roads, Sector 10, Panchkula, Haryana, to support pharmaceutical entrepreneurs and to develop their business operations through existing ecosystem improvements. More than 300 pharmaceutical companies from across the country participated.
The pharmaceutical industry plays a crucial role in society. Its impact goes beyond factories and medicine production, focusing on providing safe healthcare and earning public trust. In India, hundreds of small and medium-sized companies work daily to deliver quality medicines to patients.
This conference functioned as more than an ordinary meeting. The event brought together MSME (Micro, Small & Medium Enterprises) pharma entrepreneurs, drug department officials, industry experts & IPF leadership under one roof.
The Goal was Simple yet Meaningful
Enhance the industry’s image through strict compliance, transparency, and ethical business practices.
International Pharma Federation (IPF)
The International Pharma Federation IPF functions as a unified organisation that protects and supports all pharmaceutical enterprises across the Micro, Small & Medium Enterprise (MSME) sector.
IPF establishes a connection between three parties:
- Pharma businesses
- Regulatory authorities
- Industry experts
- Young & upcoming entrepreneurs
The IPF organisation emphasises that business development must occur alongside regulatory compliance. A strong pharma industry requires companies to abide by regulations that safeguard patients and create employment opportunities while making valuable contributions to their home countries.
IPF uses conferences, awareness programs, training sessions, and discussions to accomplish its goal of educational programs for pharma entrepreneurs, which feature information about ethical business practices, regulatory compliance details, and activities that will enhance pharma industry public relations work.
The Panchkula Conference: A National Gathering of Pharma MSMEs
The Panchkula conference saw broad attendance from entrepreneurs nationwide, drawing participants from many states to engage in key industry discussions.
The event achieved greater significance because senior executives from the drug department attended as guests. Their participation demonstrated that regulators and industry can work together, rather than against each other.
The conference program covered:
- All essential pharma matters received discussion.
- All practical information was distributed to attendees.
- The program created incentives for young entrepreneurs to develop their skills.
- The team assigned to this project focused on achieving compliance standards while maintaining top-quality assurance.
The industry benefits from this type of interaction because it establishes trust, transparency, and industry confidence.
Opening Remarks by the President: Setting the Right Direction
The IPF leadership delivered their opening statements, which created a professional atmosphere that lasted through the conference.
The statement emphasised that:-
- Pharma MSMEs are not weak players.
- The organisations maintain their obligations to both healthcare and employment.
- The organisations need to be treated with respect through transparent communication and equitable treatment.
- The leadership showed that pharma entrepreneurship requires difficult work, yet entrepreneurs can achieve ethical success through proper support and guidance.
Redefining PCD: From Perception to Purpose
PCD Means Pharma Channel Development
The conference’s main demonstration established IPF as its central organisation, which maintains unambiguous support for PCD.
IPF officially presented PCD as “Pharma Channel Development”, not as a negative or misleading concept.
Statement by IPF Spokesperson – Mr Surender Rathi
Mr Surender Rathi clearly stated:
- “We follow the same compliance standards as other pharmaceutical companies.
- We also provide quality medicines to patients.
- We should not be linked with misleading labels like ‘propaganda’.
- We are partners in progress & contribute to employment for over 2 lakh people across India.
- Any attempt to weaken us is unacceptable.”
Why Was This Clarification Necessary?
The PCD model has been misunderstood by certain groups for several years. IPF clarified that:
- PCD companies operate under identical legal and regulatory frameworks
- The organisation maintains all required quality standards.
- All documentation requirements, plus storage needs, plus marketing obligations, plus compliance duties must be fulfilled.
- PCD functions as a support system for delivering medicines to their final destinations
- The program creates numerous job opportunities throughout its operations.
The presence of senior drug department officials showed that regulation is about guidance, not harassment.
Key Knowledge Sessions & Learnings
1.New SOPs in Manufacturing & Marketing
Speaker: Mr. Sushant Sharma (CDSCO – North Zone)
Mr Sharma shared insights on:
- Updated SOPs (Standard Operating Procedures)
- Best practices in manufacturing
- Responsible marketing methods
- Documentation and traceability
His session helped entrepreneurs understand that strong SOPs protect both business and patients.
2. Pharma Protocol Quiz: Learning Through Engagement
Speaker: Mr Lalit Goyal (Haryana State Drug Controller)
Mr Goyal organised a pharma protocols quiz for young entrepreneurs, which used interactive teaching methods.
The session achieved three objectives, which included:
- Improved understanding of regulatory matters
- Encouraged active participation from attendees
- Made learning simple & Practical
The study found that people can understand that regulatory knowledge does not have to be difficult.
3. Preventing Drug Misuse
Speaker: Mr Sanjeev Garg (Drug Controller, Punjab)
Mr Garg highlighted:
Campaigns to prevent drug abuse
- Importance of responsible distribution
- Role of pharma companies in public safety
This session reminded everyone that business success should never come at the cost of public health.
4. Storage & Expiry Management
Speaker: Mr Ripan Mehta
Mr Mehta delivered an energetic and practical talk on:
Proper storage conditions
- Temperature control
- Expiry management
- Stock rotation
He explained in simple terms that:
A good medicine can become a bad medicine if stored incorrectly.
5. Support Systems for Pharma Companies
Speaker: Mr Amit Duggal
Mr Duggal spoke about:
Financial support
- Industry resources
- Advisory systems
- Growth support mechanisms
This session gave confidence to MSMEs that help and systems are available if approached correctly.
Special Guests Who Strengthened the Event
The event was honoured by the presence of:
- Mr Praveen Kumar (DCO Panchkula)
- Mr. Amit Lakhanpal
- Mr Tajinder Singh (Drug Inspector, Chandigarh)
Their presence reinforced the message that regulators and industry are partners, not enemies.
Leadership & Team IPF: Collective Responsibility
The success of the conference was driven by the collective efforts of IPF leadership and committee members:
- Mr. Sanjay Sinha – Chairman
- Mr. Gulshan Rawat – President
- Mr. Neeraj Giri – General Secretary
- Mr. Surender Rathi – Spokesperson
- Mr. Pankaj Goyal – Treasurer
- Mr. Ankush Khanna – Vice President
- Mr. Manoj Nigam – Organising Secretary
- Mr. Vivek Nasa – Events Coordinator
- Mr. Saurabh Juneja – Joint Secretary
- Mr. Vishal Agrawal – Co-Treasurer
- Mr. Sajjan Garg – CFO
Their teamwork showed that strong organisations are built by collective effort, not individuals alone.
Employment Generation: Pharma as a Nation Builder
One of the strongest points highlighted was employment generation.
PCD and MSME pharma companies together provide jobs to:
- Medical representatives
- Pharmacists
- Warehouse staff
- QA/QC professionals
- Office and logistics teams
More than 2 lakh people earn their livelihood through this ecosystem.
This makes the pharma channel a significant contributor to India’s economy.
Transparency, Quality & Compliance: The IPF Core Values
IPF clearly stated that:
- Transparency is non-negotiable
- Quality is a responsibility.
- Compliance is mandatory
IPF does not support shortcuts or unethical practices. Instead, it promotes:
- Correct documentation
- Honest marketing
- Proper storage
- Legal distribution
Challenges Faced by Pharma MSMEs
The conference also openly discussed challenges such as:
- Negative perception
- Regulatory confusion
- Market pressure
- Misinformation
IPF believes that dialogue and education are the solutions, not blame.
What IPF Plans Next: The Future Roadmap
IPF General Secretary Mr Neeraj Giri clearly stated that IPF will continue such programs regularly.
Future Plans Include:
- More compliance awareness programs
- Regular industry-regulator interactions
- Training sessions for young entrepreneurs
- Image-building initiatives for ethical pharma
- Stronger transparency frameworks
The aim is to create a responsible, educated & respected pharma ecosystem.
Conclusion
The Panchkula conference functioned as a crucial platform that delivered a definitive message regarding the Indian pharmaceutical sector. The work demonstrated that pharmaceutical SMEs possess actual significance, while PCD stands for Pharma Channel Development, and companies need to achieve both compliance requirements and business expansion.
The discussions show that transparent systems create trustworthy relationships, while organisations should maintain their strength through shared unity. The IPF group’s commitment to advance its ethical business practices aims to create an Indian pharmaceutical industry that operates with greater integrity & earns societal recognition through its operations.
Contact Information
Name: International Pharma Federation
Phone: +91 8814892777
Address: Plot No 363, 2nd floor, Industrial Area Phase 1, Panchkula, Haryana, India 134113
Email: pharmafederationorg@gmail.com
Frequently Asked Questions
Que1. Who came to this conference?
Ans. MSME (Micro, Small & Medium Enterprises), pharma traders, and other industry personalities with an eye on the future.
Que2. What does PCD mean as per IPF?
Ans. PCD stands for Pharma Channel Development.
Que3. Why was PCD redefined?
Ans. To remove misconceptions and highlight its ethical role.
Que4. Why was PCD redefined?
Ans. Redefine enlightening people while it destroys the antiquated look of corruption associated with PCD, and returns it to some noble work.
Que5. What was the role of drug inspectors?
Ans. They guided on safety practices and protocols in guidelines & SOPs.
Que6. How can IPF help pharma MSMEs?
Ans. To educate them and provide a helping hand to the industry.